{"transactions":[{"id":758845,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":15446,"kind":"person","name":"Lotvin Alan","position":1,"cik":"0001472795","reported_name":"Lotvin Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director stock option (right to buy)","published_at":"2026-05-29T20:07:30.000Z","date":"2026-05-28","kind":"grant","planned":false,"acquired":true,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options were granted under the Issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest in full on the sooner of the one-year anniversary of the date of grant or the date of Company's next annual general shareholder meeting."}],"balance_after":135000,"derivative":{"exercise_price":1.81,"expiration_date":"2036-05-28","underlying":"Class A Common Stock","underlying_shares":135000},"source":{"system":"sec-edgar","filing":"0001193125-26-248262","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000119312526248262/ownership.xml","form_type":"4"}},{"id":1127791,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":15446,"kind":"person","name":"Lotvin Alan","position":1,"cik":"0001472795","reported_name":"Lotvin Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director stock option (right to buy)","published_at":"2025-06-02T20:12:15.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":125862,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options were granted under the Issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest in full on the sooner of the one-year anniversary of the date of grant or the date of Company's next annual general shareholder meeting."}],"balance_after":125862,"derivative":{"exercise_price":0.72,"expiration_date":"2035-05-29","underlying":"Class A Ordinary Shares","underlying_shares":125862},"source":{"system":"sec-edgar","filing":"0000950170-25-080260","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017025080260/ownership.xml","form_type":"4"}},{"id":1495279,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":15446,"kind":"person","name":"Lotvin Alan","position":1,"cik":"0001472795","reported_name":"Lotvin Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director stock option (right to buy)","published_at":"2024-06-03T20:31:06.000Z","date":"2024-05-30","kind":"grant","planned":false,"acquired":true,"shares":62558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options were granted under the Issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest in full on the sooner of the one-year anniversary of the date of grant or the date of Company's next annual general shareholder meeting."}],"balance_after":62558,"derivative":{"exercise_price":4.2,"expiration_date":"2034-05-30","underlying":"Class A Ordinary Shares","underlying_shares":62558},"source":{"system":"sec-edgar","filing":"0000950170-24-068034","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095017024068034/ownership.xml","form_type":"4"}},{"id":1839819,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":15446,"kind":"person","name":"Lotvin Alan","position":1,"cik":"0001472795","reported_name":"Lotvin Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director stock option (right to buy)","published_at":"2023-07-03T13:16:51.000Z","date":"2023-06-29","kind":"grant","planned":false,"acquired":true,"shares":48128,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These options were granted under the Issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest in full on the sooner of the one-year anniversary of the date of grant or the date of Company's next annual general shareholder meeting."}],"balance_after":48128,"derivative":{"exercise_price":10.56,"expiration_date":"2033-06-29","underlying":"Class A Ordinary Shares","underlying_shares":48128},"source":{"system":"sec-edgar","filing":"0001209191-23-040422","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000120919123040422/doc4.xml","form_type":"4"}},{"id":359102,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":15446,"kind":"person","name":"Lotvin Alan","position":1,"cik":"0001472795","reported_name":"Lotvin Alan","relationship":{"officer":true,"officer_title":"EVP&President-PharmacyServices"}}],"security":"Stock Option","published_at":"2022-08-05T20:50:47.000Z","date":"2022-08-04","kind":"exercise","acquired":false,"shares":22541,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Option became exercisable in four equal annual installments, commencing 4/1/2019."}],"balance_after":0,"derivative":{"exercise_price":62.21,"exercise_date":"2019-04-01","expiration_date":"2025-04-01","underlying":"Common Stock","underlying_shares":22541},"source":{"system":"sec-edgar","filing":"0001127602-22-020596","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/64803/000112760222020596/form4.xml","form_type":"4"}},{"id":359101,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":15446,"kind":"person","name":"Lotvin Alan","position":1,"cik":"0001472795","reported_name":"Lotvin Alan","relationship":{"officer":true,"officer_title":"EVP&President-PharmacyServices"}}],"security":"Stock Option","published_at":"2022-08-05T20:50:47.000Z","date":"2022-08-03","kind":"exercise","acquired":false,"shares":50501,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option became exercisable in four equal annual installments, commencing 4/1/2020."}],"balance_after":20201,"derivative":{"exercise_price":54.19,"exercise_date":"2020-04-01","expiration_date":"2029-04-01","underlying":"Common Stock","underlying_shares":50501},"source":{"system":"sec-edgar","filing":"0001127602-22-020596","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/64803/000112760222020596/form4.xml","form_type":"4"}},{"id":359100,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":15446,"kind":"person","name":"Lotvin Alan","position":1,"cik":"0001472795","reported_name":"Lotvin Alan","relationship":{"officer":true,"officer_title":"EVP&President-PharmacyServices"}}],"security":"Stock Option","published_at":"2022-08-05T20:50:47.000Z","date":"2022-08-03","kind":"exercise","acquired":false,"shares":70398,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The number of shares subject to the option were calculated using a 30-day average price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option became exercisable in four equal annual installments, commencing 4/1/2021."}],"balance_after":70399,"derivative":{"exercise_price":58.34,"exercise_date":"2021-04-01","expiration_date":"2030-04-01","underlying":"Common Stock","underlying_shares":70398},"source":{"system":"sec-edgar","filing":"0001127602-22-020596","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/64803/000112760222020596/form4.xml","form_type":"4"}},{"id":359099,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":15446,"kind":"person","name":"Lotvin Alan","position":1,"cik":"0001472795","reported_name":"Lotvin Alan","relationship":{"officer":true,"officer_title":"EVP&President-PharmacyServices"}}],"security":"Common Stock","published_at":"2022-08-05T20:50:47.000Z","date":"2022-08-04","kind":"sale","acquired":false,"shares":22541,"price":104,"value":2344264.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales were effected pursuant to a Rule 10b5-1 plan."}],"balance_after":109183.3689,"source":{"system":"sec-edgar","filing":"0001127602-22-020596","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/64803/000112760222020596/form4.xml","form_type":"4"}},{"id":359098,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":15446,"kind":"person","name":"Lotvin Alan","position":1,"cik":"0001472795","reported_name":"Lotvin Alan","relationship":{"officer":true,"officer_title":"EVP&President-PharmacyServices"}}],"security":"Common Stock","published_at":"2022-08-05T20:50:47.000Z","date":"2022-08-04","kind":"exercise","acquired":true,"shares":22541,"price":62.21,"value":1402275.61,"ownership":{"direct":true},"balance_after":131724.3689,"source":{"system":"sec-edgar","filing":"0001127602-22-020596","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/64803/000112760222020596/form4.xml","form_type":"4"}},{"id":359097,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":15446,"kind":"person","name":"Lotvin Alan","position":1,"cik":"0001472795","reported_name":"Lotvin Alan","relationship":{"officer":true,"officer_title":"EVP&President-PharmacyServices"}}],"security":"Common Stock","published_at":"2022-08-05T20:50:47.000Z","date":"2022-08-03","kind":"sale","acquired":false,"shares":50501,"price":98,"value":4949098.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales were effected pursuant to a Rule 10b5-1 plan."}],"balance_after":109183.3689,"source":{"system":"sec-edgar","filing":"0001127602-22-020596","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/64803/000112760222020596/form4.xml","form_type":"4"}},{"id":359096,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":15446,"kind":"person","name":"Lotvin Alan","position":1,"cik":"0001472795","reported_name":"Lotvin Alan","relationship":{"officer":true,"officer_title":"EVP&President-PharmacyServices"}}],"security":"Common Stock","published_at":"2022-08-05T20:50:47.000Z","date":"2022-08-03","kind":"exercise","acquired":true,"shares":50501,"price":54.19,"value":2736649.19,"ownership":{"direct":true},"balance_after":159684.3689,"source":{"system":"sec-edgar","filing":"0001127602-22-020596","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/64803/000112760222020596/form4.xml","form_type":"4"}},{"id":359095,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":15446,"kind":"person","name":"Lotvin Alan","position":1,"cik":"0001472795","reported_name":"Lotvin Alan","relationship":{"officer":true,"officer_title":"EVP&President-PharmacyServices"}}],"security":"Common Stock","published_at":"2022-08-05T20:50:47.000Z","date":"2022-08-03","kind":"sale","acquired":false,"shares":70398,"price":98,"value":6899004.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales were effected pursuant to a Rule 10b5-1 plan."}],"balance_after":109183.3689,"source":{"system":"sec-edgar","filing":"0001127602-22-020596","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/64803/000112760222020596/form4.xml","form_type":"4"}},{"id":359094,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":15446,"kind":"person","name":"Lotvin Alan","position":1,"cik":"0001472795","reported_name":"Lotvin Alan","relationship":{"officer":true,"officer_title":"EVP&President-PharmacyServices"}}],"security":"Common Stock","published_at":"2022-08-05T20:50:47.000Z","date":"2022-08-03","kind":"exercise","acquired":true,"shares":70398,"price":58.34,"value":4107019.32,"ownership":{"direct":true},"balance_after":179581.3689,"source":{"system":"sec-edgar","filing":"0001127602-22-020596","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/64803/000112760222020596/form4.xml","form_type":"4"}},{"id":2208105,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":15446,"kind":"person","name":"Lotvin Alan","position":1,"cik":"0001472795","reported_name":"Lotvin Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Units in ProKidney LP","published_at":"2022-07-14T01:29:09.000Z","date":"2022-07-11","kind":"grant","acquired":true,"shares":1514326,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Each Common Unit may, at the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and the Second Amended and Restated Company Partnership Agreement, be exchanged, together with the paired Class B Ordinary Share, into a Class A Ordinary Share on a one-for-one basis."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Common Unit may, at the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and the Second Amended and Restated Company Partnership Agreement, be exchanged, together with the paired Class B Ordinary Share, into a Class A Ordinary Share on a one-for-one basis."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"These 1,350,469 Common Units and 163,857 Restricted Common Units of ProKidney Equity LLC that upon vesting will settle in Common Units (\"PMEL RCUs\") were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney. The PMEL RCUs vest in installments over a period through January 17, 2025. The Common Units and the PMEL RCUs do not expire."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These 1,350,469 Common Units and 163,857 Restricted Common Units of ProKidney Equity LLC that upon vesting will settle in Common Units (\"PMEL RCUs\") were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney. The PMEL RCUs vest in installments over a period through January 17, 2025. The Common Units and the PMEL RCUs do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These 1,350,469 Common Units and 163,857 Restricted Common Units of ProKidney Equity LLC that upon vesting will settle in Common Units (\"PMEL RCUs\") were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney. The PMEL RCUs vest in installments over a period through January 17, 2025. The Common Units and the PMEL RCUs do not expire."}],"balance_after":1514326,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":1514326},"source":{"system":"sec-edgar","filing":"0000950103-22-012369","document":"dp177038_4-lotvin.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095010322012369/dp177038_4-lotvin.xml","form_type":"4"}},{"id":2208104,"issuer":{"id":5181,"kind":"organization","name":"PROKIDNEY CORP."},"owners":[{"id":15446,"kind":"person","name":"Lotvin Alan","position":1,"cik":"0001472795","reported_name":"Lotvin Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Ordinary Shares","published_at":"2022-07-14T01:29:09.000Z","date":"2022-07-11","kind":"grant","acquired":true,"shares":1514326,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Class B Ordinary Share has no economic rights but entitles the reporting person to vote on all matters on which shareholders of the issuer vote and may, at the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and the Second Amended and Restated Company Partnership Agreement (each as defined and as described in the issuer's Definitive Proxy Statement filed with the Securities and Exchange Commission on June 10, 2022), be exchanged, together with the paired Common Unit in ProKidney LP (\"ProKidney\") (a \"Common Unit\"), for a Class A Ordinary Share on a one-for-one basis."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"These 1,350,469 Class B Ordinary Shares and 163,857 Restricted Stock Rights in respect of Class B Ordinary Shares (\"Class B PMEL RSRs\") were received pursuant to the terms of the Business Combination Agreement by and between the issuer and ProKidney, dated as of January 18, 2022 (the \"Business Combination Agreement\") in exchange for historical interests held by the reporting person in ProKidney. The Class B PMEL RSRs vest in installments over a period through January 17, 2025, and upon vesting are immediately settled as Class B Ordinary Shares. The Class B Ordinary Shares and Class B PMEL RSRs do not expire."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These 1,350,469 Class B Ordinary Shares and 163,857 Restricted Stock Rights in respect of Class B Ordinary Shares (\"Class B PMEL RSRs\") were received pursuant to the terms of the Business Combination Agreement by and between the issuer and ProKidney, dated as of January 18, 2022 (the \"Business Combination Agreement\") in exchange for historical interests held by the reporting person in ProKidney. The Class B PMEL RSRs vest in installments over a period through January 17, 2025, and upon vesting are immediately settled as Class B Ordinary Shares. The Class B Ordinary Shares and Class B PMEL RSRs do not expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These 1,350,469 Class B Ordinary Shares and 163,857 Restricted Stock Rights in respect of Class B Ordinary Shares (\"Class B PMEL RSRs\") were received pursuant to the terms of the Business Combination Agreement by and between the issuer and ProKidney, dated as of January 18, 2022 (the \"Business Combination Agreement\") in exchange for historical interests held by the reporting person in ProKidney. The Class B PMEL RSRs vest in installments over a period through January 17, 2025, and upon vesting are immediately settled as Class B Ordinary Shares. The Class B Ordinary Shares and Class B PMEL RSRs do not expire."}],"balance_after":1514326,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":1514326},"source":{"system":"sec-edgar","filing":"0000950103-22-012369","document":"dp177038_4-lotvin.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850270/000095010322012369/dp177038_4-lotvin.xml","form_type":"4"}},{"id":362998,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":15446,"kind":"person","name":"Lotvin Alan","position":1,"cik":"0001472795","reported_name":"Lotvin Alan","relationship":{"officer":true,"officer_title":"EVP&President-PharmacyServices"}}],"security":"Stock Option","published_at":"2022-04-05T23:28:00.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":77962,"price":101.09,"value":7881178.58,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option becomes exercisable in four equal installments, commencing 4/1/2023."}],"balance_after":77962,"derivative":{"exercise_price":101.09,"exercise_date":"2023-04-01","expiration_date":"2032-04-01","underlying":"Common Stock","underlying_shares":77962},"source":{"system":"sec-edgar","filing":"0001127602-22-011636","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/64803/000112760222011636/form4.xml","form_type":"4"}},{"id":362997,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":15446,"kind":"person","name":"Lotvin Alan","position":1,"cik":"0001472795","reported_name":"Lotvin Alan","relationship":{"officer":true,"officer_title":"EVP&President-PharmacyServices"}}],"security":"Common Stock","published_at":"2022-04-05T23:28:00.000Z","date":"2022-04-01","kind":"tax_withholding","acquired":false,"shares":38129,"price":101.09,"value":3854460.61,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Surrender of shares in payment of taxes due upon the vesting and settlement of PSUs on April 1, 2022."}],"balance_after":109183.3689,"source":{"system":"sec-edgar","filing":"0001127602-22-011636","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/64803/000112760222011636/form4.xml","form_type":"4"}},{"id":365376,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":15446,"kind":"person","name":"Lotvin Alan","position":1,"cik":"0001472795","reported_name":"Lotvin Alan","relationship":{"officer":true,"officer_title":"EVP&President-PharmacyServices"}}],"security":"Common Stock","published_at":"2022-02-23T21:26:50.000Z","date":"2022-02-21","kind":"grant","acquired":true,"shares":85971,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares earned by the reporting person pursuant to certain performance stock units (the \"PSUs\"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on June 5, 2019. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 21, 2022."}],"balance_after":147312.3689,"source":{"system":"sec-edgar","filing":"0001127602-22-006291","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/64803/000112760222006291/form4.xml","form_type":"4"}},{"id":366855,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":15446,"kind":"person","name":"Lotvin Alan","position":1,"cik":"0001472795","reported_name":"Lotvin Alan","relationship":{"officer":true,"officer_title":"EVP&President-PharmacyServices"}}],"security":"Stock Option","published_at":"2022-02-02T21:20:38.000Z","date":"2022-02-01","kind":"exercise","acquired":false,"shares":21386,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option became exercisable in four equal annual installments, commencing 4/1/2016."}],"balance_after":0,"derivative":{"exercise_price":102.26,"exercise_date":"2016-04-01","expiration_date":"2022-04-01","underlying":"Common Stock","underlying_shares":21386},"source":{"system":"sec-edgar","filing":"0001127602-22-002958","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/64803/000112760222002958/form4.xml","form_type":"4"}},{"id":366854,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":15446,"kind":"person","name":"Lotvin Alan","position":1,"cik":"0001472795","reported_name":"Lotvin Alan","relationship":{"officer":true,"officer_title":"EVP&President-PharmacyServices"}}],"security":"Common Stock","published_at":"2022-02-02T21:20:38.000Z","date":"2022-02-01","kind":"sale","acquired":false,"shares":21386,"price":106.498,"value":2277566.228,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales were effected pursuant to a Rule 10b5-1 plan."}],"balance_after":61341.3689,"source":{"system":"sec-edgar","filing":"0001127602-22-002958","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/64803/000112760222002958/form4.xml","form_type":"4"}},{"id":366853,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":15446,"kind":"person","name":"Lotvin Alan","position":1,"cik":"0001472795","reported_name":"Lotvin Alan","relationship":{"officer":true,"officer_title":"EVP&President-PharmacyServices"}}],"security":"Common Stock","published_at":"2022-02-02T21:20:38.000Z","date":"2022-02-01","kind":"exercise","acquired":true,"shares":21386,"price":102.26,"value":2186932.36,"ownership":{"direct":true},"balance_after":82727.3689,"source":{"system":"sec-edgar","filing":"0001127602-22-002958","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/64803/000112760222002958/form4.xml","form_type":"4"}},{"id":368179,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":15446,"kind":"person","name":"Lotvin Alan","position":1,"cik":"0001472795","reported_name":"Lotvin Alan","relationship":{"officer":true,"officer_title":"EVP&President-PharmacyServices"}}],"security":"Common Stock (restricted)","published_at":"2021-12-28T22:04:30.000Z","date":"2021-12-27","kind":"tax_withholding","acquired":false,"shares":200,"price":88.78,"value":17756.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction represents the withholding of shares by the Issuer to satisfy FICA taxes arising from the reporting person being retirement eligible."}],"balance_after":5827,"source":{"system":"sec-edgar","filing":"0001127602-21-031962","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/64803/000112760221031962/form4.xml","form_type":"4"}},{"id":374013,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":15446,"kind":"person","name":"Lotvin Alan","position":1,"cik":"0001472795","reported_name":"Lotvin Alan","relationship":{"officer":true,"officer_title":"EVP&President-PharmacyServices"}}],"security":"Common Stock","published_at":"2021-06-29T21:43:16.000Z","date":"2021-06-28","kind":"sale","acquired":false,"shares":2781,"price":83.67,"value":232686.27,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales were effected pursuant to a Rule 10b5-1 plan."}],"balance_after":61047.6756,"source":{"system":"sec-edgar","filing":"0001127602-21-020816","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/64803/000112760221020816/form4.xml","form_type":"4"}},{"id":377074,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":15446,"kind":"person","name":"Lotvin Alan","position":1,"cik":"0001472795","reported_name":"Lotvin Alan","relationship":{"officer":true,"officer_title":"EVP&President-PharmacyServices"}}],"security":"Common Stock","published_at":"2021-04-05T21:38:59.000Z","date":"2021-04-03","kind":"tax_withholding","acquired":false,"shares":1705,"price":74.3,"value":126681.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Surrender of shares in payment of taxes due upon the vesting and settlement of a restricted stock unit award on April 3, 2021."}],"balance_after":63828.6756,"source":{"system":"sec-edgar","filing":"0001127602-21-013214","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/64803/000112760221013214/form4.xml","form_type":"4"}},{"id":377219,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":15446,"kind":"person","name":"Lotvin Alan","position":1,"cik":"0001472795","reported_name":"Lotvin Alan","relationship":{"officer":true,"officer_title":"EVP&President-PharmacyServices"}}],"security":"Stock Option","published_at":"2021-04-02T21:16:59.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":120940,"price":74.3,"value":8985842.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option becomes exercisable in four equal installments, commencing 4/1/2022."}],"balance_after":120940,"derivative":{"exercise_price":74.3,"exercise_date":"2022-04-01","expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":120940},"source":{"system":"sec-edgar","filing":"0001127602-21-012762","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/64803/000112760221012762/form4.xml","form_type":"4"}},{"id":377218,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":15446,"kind":"person","name":"Lotvin Alan","position":1,"cik":"0001472795","reported_name":"Lotvin Alan","relationship":{"officer":true,"officer_title":"EVP&President-PharmacyServices"}}],"security":"Common Stock","published_at":"2021-04-02T21:16:59.000Z","date":"2021-04-01","kind":"tax_withholding","acquired":false,"shares":42431,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Surrender of shares in payment of taxes due upon the vesting and settlement of the PSUs on April 1, 2021."}],"balance_after":61690.6756,"source":{"system":"sec-edgar","filing":"0001127602-21-012762","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/64803/000112760221012762/form4.xml","form_type":"4"}},{"id":377217,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":15446,"kind":"person","name":"Lotvin Alan","position":1,"cik":"0001472795","reported_name":"Lotvin Alan","relationship":{"officer":true,"officer_title":"EVP&President-PharmacyServices"}}],"security":"Common Stock","published_at":"2021-04-02T21:16:59.000Z","date":"2021-02-01","kind":"grant","acquired":true,"shares":95669,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares earned by the reporting person pursuant to certain performance stock units (the \"PSUs\"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on February 1, 2021.  The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 1, 2021.  The PSUs vested and settled on April 1, 2021."}],"balance_after":104121.6756,"source":{"system":"sec-edgar","filing":"0001127602-21-012762","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/64803/000112760221012762/form4.xml","form_type":"4"}},{"id":381682,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":15446,"kind":"person","name":"Lotvin Alan","position":1,"cik":"0001472795","reported_name":"Lotvin Alan","relationship":{"officer":true,"officer_title":"EVP and President-CVS Caremark"}}],"security":"Stock Option","published_at":"2021-01-12T22:43:15.000Z","date":"2021-01-08","kind":"exercise","acquired":false,"shares":15736,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Remaining options became exercisable in four equal annual installments beginning on 4/1/2015."}],"balance_after":0,"derivative":{"exercise_price":74.29,"exercise_date":"2015-04-01","expiration_date":"2021-04-01","underlying":"Common Stock","underlying_shares":15736},"source":{"system":"sec-edgar","filing":"0001127602-21-001522","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/64803/000112760221001522/form4.xml","form_type":"4"}},{"id":381681,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":15446,"kind":"person","name":"Lotvin Alan","position":1,"cik":"0001472795","reported_name":"Lotvin Alan","relationship":{"officer":true,"officer_title":"EVP and President-CVS Caremark"}}],"security":"Stock Option","published_at":"2021-01-12T22:43:15.000Z","date":"2021-01-08","kind":"exercise","acquired":false,"shares":10100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option became exercisable in four equal annual installments, commencing 4/1/2020."}],"balance_after":70702,"derivative":{"exercise_price":54.19,"exercise_date":"2020-04-01","expiration_date":"2029-04-01","underlying":"Common Stock","underlying_shares":10100},"source":{"system":"sec-edgar","filing":"0001127602-21-001522","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/64803/000112760221001522/form4.xml","form_type":"4"}},{"id":381680,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":15446,"kind":"person","name":"Lotvin Alan","position":1,"cik":"0001472795","reported_name":"Lotvin Alan","relationship":{"officer":true,"officer_title":"EVP and President-CVS Caremark"}}],"security":"Common Stock","published_at":"2021-01-12T22:43:15.000Z","date":"2021-01-08","kind":"sale","acquired":false,"shares":25836,"price":75,"value":1937700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales were effected pursuant to a Rule 10b5-1 Trading Plan."}],"balance_after":8368.6799,"source":{"system":"sec-edgar","filing":"0001127602-21-001522","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/64803/000112760221001522/form4.xml","form_type":"4"}},{"id":381679,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":15446,"kind":"person","name":"Lotvin Alan","position":1,"cik":"0001472795","reported_name":"Lotvin Alan","relationship":{"officer":true,"officer_title":"EVP and President-CVS Caremark"}}],"security":"Common Stock","published_at":"2021-01-12T22:43:15.000Z","date":"2021-01-08","kind":"exercise","acquired":true,"shares":15736,"price":74.29,"value":1169027.44,"ownership":{"direct":true},"balance_after":34204.6799,"source":{"system":"sec-edgar","filing":"0001127602-21-001522","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/64803/000112760221001522/form4.xml","form_type":"4"}},{"id":381678,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":15446,"kind":"person","name":"Lotvin Alan","position":1,"cik":"0001472795","reported_name":"Lotvin Alan","relationship":{"officer":true,"officer_title":"EVP and President-CVS Caremark"}}],"security":"Common Stock","published_at":"2021-01-12T22:43:15.000Z","date":"2021-01-08","kind":"exercise","acquired":true,"shares":10100,"price":54.19,"value":547319.0,"ownership":{"direct":true},"balance_after":18468.6799,"source":{"system":"sec-edgar","filing":"0001127602-21-001522","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/64803/000112760221001522/form4.xml","form_type":"4"}},{"id":383847,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":15446,"kind":"person","name":"Lotvin Alan","position":1,"cik":"0001472795","reported_name":"Lotvin Alan","relationship":{"officer":true,"officer_title":"EVP and President-CVS Caremark"}}],"security":"Common Stock","published_at":"2020-11-17T21:22:46.000Z","date":"2020-11-13","kind":"sale","acquired":false,"shares":7138,"price":70,"value":499660.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All sales were effected pursuant to a Rule 10b5-1 plan."}],"balance_after":8023.3273,"source":{"system":"sec-edgar","filing":"0001127602-20-029248","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/64803/000112760220029248/form4.xml","form_type":"4"}},{"id":390720,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":15446,"kind":"person","name":"Lotvin Alan","position":1,"cik":"0001472795","reported_name":"Lotvin Alan","relationship":{"officer":true,"officer_title":"EVP and President-CVS Caremark"}}],"security":"Common Stock","published_at":"2020-05-13T13:08:48.000Z","date":"2020-05-11","kind":"purchase","acquired":true,"shares":5000,"price":63.135,"value":315675.0,"ownership":{"direct":true},"balance_after":15161.3273,"source":{"system":"sec-edgar","filing":"0001127602-20-016337","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/64803/000112760220016337/form4.xml","form_type":"4"}},{"id":392111,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":15446,"kind":"person","name":"Lotvin Alan","position":1,"cik":"0001472795","reported_name":"Lotvin Alan","relationship":{"officer":true,"officer_title":"EVP, Transformation"}}],"security":"Stock Option","published_at":"2020-04-07T21:39:31.000Z","date":"2020-04-01","kind":"grant","acquired":true,"shares":140797,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This Form 4/A is being filed in order to correct the exercise price (Table II, column 2) for the stock option granted on 4/1/2020, which was reported incorrectly on the original Form 4 due to a clerical error."}],"balance_after":140797,"derivative":{"exercise_price":58.34,"exercise_date":"2021-04-01","expiration_date":"2030-04-01","underlying":"Common Stock","underlying_shares":140797},"source":{"system":"sec-edgar","filing":"0001127602-20-013410","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/64803/000112760220013410/form4a.xml","form_type":"4/A","original_submission_date":"2020-04-03"}},{"id":392210,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":15446,"kind":"person","name":"Lotvin Alan","position":1,"cik":"0001472795","reported_name":"Lotvin Alan","relationship":{"officer":true,"officer_title":"EVP, Transformation"}}],"security":"Stock Option","published_at":"2020-04-03T21:32:04.000Z","date":"2020-04-01","kind":"grant","acquired":true,"shares":140797,"price":58.61,"value":8252112.17,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The number of shares subject to the option were calculated using a 30-day average price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option becomes exercisable in four equal annual installments, commencing 4/1/2021."}],"balance_after":140797,"derivative":{"exercise_price":58.61,"exercise_date":"2021-04-01","expiration_date":"2030-04-01","underlying":"Common Stock","underlying_shares":140797},"source":{"system":"sec-edgar","filing":"0001127602-20-013234","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/64803/000112760220013234/form4.xml","form_type":"4"}},{"id":392209,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":15446,"kind":"person","name":"Lotvin Alan","position":1,"cik":"0001472795","reported_name":"Lotvin Alan","relationship":{"officer":true,"officer_title":"EVP, Transformation"}}],"security":"Common Stock","published_at":"2020-04-03T21:32:04.000Z","date":"2020-04-01","kind":"tax_withholding","acquired":false,"shares":1481,"price":58.34,"value":86401.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award."}],"balance_after":10161.3273,"source":{"system":"sec-edgar","filing":"0001127602-20-013234","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/64803/000112760220013234/form4.xml","form_type":"4"}},{"id":393996,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":15446,"kind":"person","name":"Lotvin Alan","position":1,"cik":"0001472795","reported_name":"Lotvin Alan","relationship":{"officer":true,"officer_title":"EVP, Transformation"}}],"security":"Stock Unit","published_at":"2020-03-03T22:41:16.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":11828,"price":59.18,"value":699981.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of Stock Units Awarded at market price pursuant to Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan, the receipt of which the reporting person has elected to defer."}],"balance_after":27945.094,"source":{"system":"sec-edgar","filing":"0001127602-20-009164","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/64803/000112760220009164/form4.xml","form_type":"4"}},{"id":393995,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":15446,"kind":"person","name":"Lotvin Alan","position":1,"cik":"0001472795","reported_name":"Lotvin Alan","relationship":{"officer":true,"officer_title":"EVP, Transformation"}}],"security":"Common Stock","published_at":"2020-03-03T22:41:16.000Z","date":"2020-02-28","kind":"tax_withholding","acquired":false,"shares":160,"price":59.18,"value":9468.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award."}],"balance_after":8303.3273,"source":{"system":"sec-edgar","filing":"0001127602-20-009164","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/64803/000112760220009164/form4.xml","form_type":"4"}},{"id":404414,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":15446,"kind":"person","name":"Lotvin Alan","position":1,"cik":"0001472795","reported_name":"Lotvin Alan","relationship":{"officer":true,"officer_title":"EVP, Transformation"}}],"security":"Stock Option","published_at":"2019-04-03T20:58:17.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":80802,"price":54.19,"value":4378660.38,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option becomes exercisable in four equal annual installments, commencing 4/1/2020."}],"balance_after":80802,"derivative":{"exercise_price":54.19,"exercise_date":"2020-04-01","expiration_date":"2029-04-01","underlying":"Common Stock","underlying_shares":80802},"source":{"system":"sec-edgar","filing":"0001127602-19-014675","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/64803/000112760219014675/form4.xml","form_type":"4"}},{"id":404413,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":15446,"kind":"person","name":"Lotvin Alan","position":1,"cik":"0001472795","reported_name":"Lotvin Alan","relationship":{"officer":true,"officer_title":"EVP, Transformation"}}],"security":"Common Stock","published_at":"2019-04-03T20:58:17.000Z","date":"2019-04-01","kind":"tax_withholding","acquired":false,"shares":863,"price":54.19,"value":46765.97,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Surrender of shares in payment of withholding taxes due upon the vesting of a stock award under an incentive compensation plan."}],"balance_after":7578.2742,"source":{"system":"sec-edgar","filing":"0001127602-19-014675","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/64803/000112760219014675/form4.xml","form_type":"4"}},{"id":406516,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":15446,"kind":"person","name":"Lotvin Alan","position":1,"cik":"0001472795","reported_name":"Lotvin Alan","relationship":{"officer":true,"officer_title":"EVP, Transformation"}}],"security":"Stock Unit","published_at":"2019-03-01T22:48:13.000Z","date":"2019-02-28","kind":"grant","acquired":true,"shares":6342,"price":57.83,"value":366757.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of Stock Units awarded at market price pursuant to Issuer's 2017 Incentive Compensation Plan and its Long-Term Incentive Plan, the receipt of which the reporting person has elected to defer."}],"balance_after":15141.1519,"source":{"system":"sec-edgar","filing":"0001127602-19-009279","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/64803/000112760219009279/form4.xml","form_type":"4"}},{"id":406515,"issuer":{"id":2884,"kind":"organization","name":"CVS HEALTH Corp"},"owners":[{"id":15446,"kind":"person","name":"Lotvin Alan","position":1,"cik":"0001472795","reported_name":"Lotvin Alan","relationship":{"officer":true,"officer_title":"EVP, Transformation"}}],"security":"Common Stock","published_at":"2019-03-01T22:48:13.000Z","date":"2019-02-28","kind":"tax_withholding","acquired":false,"shares":292,"price":57.83,"value":16886.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"SurreSurrender of shares in payment of withholding taxes due upon the vesting of restricted stock awards under the Issuer's 2017 Incentive Compensation Plan."}],"balance_after":5508.2742,"source":{"system":"sec-edgar","filing":"0001127602-19-009279","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/64803/000112760219009279/form4.xml","form_type":"4"}}]}